Ventricular Ectopy Associated with Low-Dose Intravenous Haloperidol and Electroconvulsive Therapy

Greene, Yvonne M.; McDonald, William M.; Duggan, Jane; Cooper, Robert B.

doi:10.1097/00124509-200009000-00015

Cited by 4 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Koo and Chien 34 describe a case of a patient who became comatose after droperidol administration for PIA, warning against its routine use in the post-ECT setting. Greene et al 35 report a case of ventricular ectopy, relieved by IV lidocaine, after haloperidol administration for PIA in a patient with previously reported left anterior fascicular block. They recommend continuous cardiac monitoring if haloperidol or other QTc-prolonging medications are used for PIA because of the risk of Torsades de Pointes and cardiac complications with IV haloperidol administration 36 …”

Section: Acute Managementmentioning

confidence: 99%

Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy

Sterina

Gregory²,

Hermida

2022

J ECT

View full text Add to dashboard Cite

Postictal agitation (PIA) is a common adverse effect of electroconvulsive therapy (ECT), a treatment used for a variety of psychiatric disorders. Because of risk of harm to patients and health providers when patients develop PIA, its acute management and prophylaxis are of vital importance for ECT practitioners. This article describes PIA risk factors, as well as practical steps to manage this ECT complication. Nonpharmacologic patient safety interventions are critical components of PIA management. Benzodiazepines, antipsychotics, and additional anesthetic doses are discussed as acute treatment interventions. Prophylactic pharmacologic choices described include antipsychotics, postseizure anesthetics, and dexmedetomidine. Exploratory choices such as melatonin and intranasal formulations of sedatives are also discussed. This review suggests that common medication like olanzapine and propofol are cost-effective considerations to decrease PIA incidence and/or severity after ECT. In addition, dexmedetomidine presents a management alternative for treatment-resistant PIA. This literature review outlines treatment choices while suggesting future directions for considering effective treatments of postictal agitation in clinical settings.

show abstract

Section: Acute Managementmentioning

confidence: 99%

Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy

Sterina

Gregory²,

Hermida

2022

J ECT

View full text Add to dashboard Cite

show abstract

Pharmacoepidemiology and drug safety

2001

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation

Hermida

Janjua

Tang

et al. 2016

Journal of Psychiatric Practice

View full text Add to dashboard Cite

A major medical problem for patients undergoing electroconvulsive therapy (ECT) is the occurrence of postictal agitation (PIA). This phenomenon is associated with confusion and disorientation that can have severe clinical implications for the safety of the patient and health care professionals. Many different pharmacological strategies have been used to prevent PIA. We present data on 40 patients who suffered from PIA after a course of ECT and evaluate the prophylactic use of orally disintegrating olanzapine in the prevention of PIA in subsequent ECT treatments.

show abstract

Ventricular Ectopy Associated with Low-Dose Intravenous Haloperidol and Electroconvulsive Therapy

Cited by 4 publications

References 8 publications

Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy

Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy

Pharmacoepidemiology and drug safety

Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation

Contact Info

Product

Resources

About